ACA Earnings & Financial Statements
Arcosa, Inc.
$146.58
+$0.08(+0.05%)
67
Overall
80
Value
66
Tech
57
Quality
Market Cap
$7.19B
Volume
15.05K
52W Range
$89.03 - $147.00
Target Price
$147.50
ACA earnings and financial statements: Arcosa, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ACA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.88B | $2.57B | $2.31B | $2.24B | $2.04B |
| Cost of revenue | $2.24B | $2.05B | $1.86B | $1.83B | $1.68B |
| Operating income | $341.90M | $197.60M | $217.30M | $349.00M | $107.30M |
| EBITDA | $573.10M | $395.90M | $383.50M | $501.30M | $251.30M |
| Net income | $208.40M | $93.70M | $159.20M | $245.80M | $69.60M |
| EPS (diluted) | $4.24 | $1.91 | $3.26 | $5.05 | $1.42 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $4.99B | $4.92B | $3.58B | $3.34B | $3.19B |
| Total liabilities | $2.34B | $2.49B | $1.25B | $1.16B | $1.23B |
| Shareholders’ equity | $2.64B | $2.43B | $2.33B | $2.18B | $1.95B |
| Cash and equivalents | $214.60M | $187.30M | $104.80M | $160.40M | $72.90M |
| Long-term debt | $1.51B | $1.68B | $561.90M | $535.90M | $664.70M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $341.10M | $502.00M | $261.00M | $174.30M | $166.50M |
| Capital expenditure | -$139.00M | -$171.40M | -$203.50M | -$138.00M | -$85.10M |
| Free cash flow | $175.50M | $312.30M | $57.50M | $36.30M | $81.40M |
| Dividends paid | $10.00M | $9.70M | $9.80M | $9.80M | $9.80M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACA | $146.58 | +0.1% | 15.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |